Douglas Coplen

Medicine & Life Sciences

1. Biopsy 19%
2. Child 52%
3. Cholinergic Antagonists 15%
4. Clear Cell Sarcoma 16%
5. Congenital Adrenal Hyperplasia 21%
6. Cryptorchidism 15%
7. Deamino Arginine Vasopressin 14%
8. Dilatation 33%
9. Disorders of Sex Development 17%
10. Diurnal Enuresis 17%
11. Doxazosin 16%
12. Enuresis 15%
13. Extracellular Matrix 14%
14. Fetus 20%
15. Genitalia 16%
16. Hydronephrosis 57%
17. Hypospadias 30%
18. Imperforate Anus 15%
19. Incidence 14%
20. Kidney 55%
21. Lower Urinary Tract Symptoms 15%
22. Neonatal Intensive Care Units 15%
23. Neoplasms 16%
24. Nephrolithiasis 14%
25. Neurogenic Urinary Bladder 13%
26. Newborn Infant 31%
27. Nocturnal Enuresis 23%
28. oxybutynin 16%
29. Pediatrics 40%
30. Placebos 14%
31. Premature Infants 20%
32. Prenatal Diagnosis 20%
33. Primary Hyperoxaluria 17%
34. Prostate-Specific Antigen 22%
35. Prostatic Neoplasms 34%
36. Recurrence 15%
37. Rete Testis 17%
38. Sexual Development 14%
39. Smooth Muscle Myocytes 31%
40. Therapeutics 16%
41. Transforming Growth Factor beta1 14%
42. Type A Botulinum Toxins 16%
43. Ultrasonography 20%
44. Ureterocele 66%
45. Urethral Obstruction 22%
46. Urinary Bladder 100%
47. Urinary Tract 55%
48. Urinary Tract Infections 37%
49. Vesico-Ureteral Reflux 43%
50. Wilms Tumor 15%